307 related articles for article (PubMed ID: 29974132)
1. Neoadjuvant chemotherapy for breast cancer-background for the indication of locoregional treatment.
Krug D; Baumann R; Budach W; Dunst J; Feyer P; Fietkau R; Haase W; Harms W; Hehr T; Piroth MD; Sedlmayer F; Souchon R; Wenz F; Sauer R;
Strahlenther Onkol; 2018 Sep; 194(9):797-805. PubMed ID: 29974132
[TBL] [Abstract][Full Text] [Related]
2. The Effect of Molecular Subtype and Residual Disease on Locoregional Recurrence in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy and Postmastectomy Radiation.
Yang TJ; Morrow M; Modi S; Zhang Z; Krause K; Siu C; McCormick B; Powell SN; Ho AY
Ann Surg Oncol; 2015 Dec; 22 Suppl 3(Suppl 3):S495-501. PubMed ID: 26130454
[TBL] [Abstract][Full Text] [Related]
3. Local radiotherapy alone following neoadjuvant chemotherapy and surgery in combined clinical stage II and III breast cancer.
White R; Dinneen T; Makris A
Radiat Oncol; 2016 Jul; 11():93. PubMed ID: 27457764
[TBL] [Abstract][Full Text] [Related]
4. Outcome of postmastectomy radiotherapy after primary systemic treatment in patients with clinical T1-2N1 breast cancer.
Cao L; Ou D; Shen KW; Cai G; Cai R; Xu F; Zhao SG; Xu C; Grellier Adedjouma N; Kirova YM; Chen JY
Cancer Radiother; 2018 Feb; 22(1):38-44. PubMed ID: 29306555
[TBL] [Abstract][Full Text] [Related]
5. Mastectomy with immediate breast reconstruction after neoadjuvant chemotherapy and radiation therapy. A new option for patients with operable invasive breast cancer. Results of a 20 years single institution study.
Monrigal E; Dauplat J; Gimbergues P; Le Bouedec G; Peyronie M; Achard JL; Chollet P; Mouret-Reynier MA; Nabholtz JM; Pomel C
Eur J Surg Oncol; 2011 Oct; 37(10):864-70. PubMed ID: 21843920
[TBL] [Abstract][Full Text] [Related]
6. Risk factors of locoregional relapse in locally advanced breast cancer treated with neoadjuvant chemotherapy following mastectomy and radiotherapy.
Huang L; Chen S; Yang WT; Shao Z
Oncotarget; 2017 Jun; 8(24):39703-39710. PubMed ID: 28055977
[TBL] [Abstract][Full Text] [Related]
7. Postmastectomy Radiotherapy After Neoadjuvant Chemotherapy: A Review of the Evidence.
Chapman CH; Jagsi R
Oncology (Williston Park); 2015 Sep; 29(9):657-66. PubMed ID: 26384802
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant chemotherapy in stage III breast cancer.
Alassas M; Chu Q; Burton G; Ampil F; Mizell J; Li BD
Am Surg; 2005 Jun; 71(6):487-92. PubMed ID: 16044927
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Follow-Up of Node-Negative Breast Cancer Patients Evaluated via Sentinel Node Biopsy After Neoadjuvant Chemotherapy.
Nogi H; Uchida K; Mimoto R; Kamio M; Shioya H; Toriumi Y; Suzuki M; Nagasaki E; Kobayashi T; Takeyama H
Clin Breast Cancer; 2017 Dec; 17(8):644-649. PubMed ID: 28601382
[TBL] [Abstract][Full Text] [Related]
10. Predictors of locoregional outcome in HER2-overexpressing breast cancer treated with neoadjuvant chemotherapy.
Arsenault D; Hurley J; Takita C; Reis IM; Zhao W; Rodgers S; Wright JL
Am J Clin Oncol; 2015 Aug; 38(4):348-52. PubMed ID: 23799288
[TBL] [Abstract][Full Text] [Related]
11. The current role of sentinel node biopsy in the treatment of breast cancer.
Grube BJ; Giuliano AE
Adv Surg; 2004; 38():121-66. PubMed ID: 15515617
[No Abstract] [Full Text] [Related]
12. Identifying accessible prognostic factors for breast cancer relapse: a case-study on 405 histologically confirmed node-negative patients.
Zemni I; Ghalleb M; Jbir I; Slimane M; Ben Hassouna J; Ben Dhieb T; Bouzaiene H; Rahal K
World J Surg Oncol; 2017 Nov; 15(1):206. PubMed ID: 29169398
[TBL] [Abstract][Full Text] [Related]
13. Residual lymph node disease after neoadjuvant chemotherapy predicts an increased risk of lymphedema in node-positive breast cancer patients.
Specht MC; Miller CL; Skolny MN; Jammallo LS; O'Toole J; Horick N; Isakoff SJ; Smith BL; Taghian AG
Ann Surg Oncol; 2013 Sep; 20(9):2835-41. PubMed ID: 23689935
[TBL] [Abstract][Full Text] [Related]
14. [Breast-conserving therapy in breast cancer].
Marcollet A; Doridot V; Nos C
Rev Prat; 2004 Apr; 54(8):847-53. PubMed ID: 15274458
[TBL] [Abstract][Full Text] [Related]
15. Local recurrence rates are low in high-risk neoadjuvant breast cancer in the I-SPY 1 Trial (CALGB 150007/150012; ACRIN 6657).
Cureton EL; Yau C; Alvarado MD; Krontiras H; Ollila DW; Ewing CA; Monnier S; Esserman LJ
Ann Surg Oncol; 2014 Sep; 21(9):2889-96. PubMed ID: 24788555
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy.
Keam B; Im SA; Kim HJ; Oh DY; Kim JH; Lee SH; Chie EK; Han W; Kim DW; Cho N; Moon WK; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
Breast Cancer Res Treat; 2009 Jul; 116(1):153-60. PubMed ID: 18787948
[TBL] [Abstract][Full Text] [Related]
17. Low risk of locoregional recurrence of primary breast carcinoma after treatment with a modification of the Halsted radical mastectomy and selective use of radiotherapy.
Bijker N; Rutgers EJ; Peterse JL; van Dongen JA; Hart AA; Borger JH; Kroon BB
Cancer; 1999 Apr; 85(8):1773-81. PubMed ID: 10223572
[TBL] [Abstract][Full Text] [Related]
18. Individualization of post-mastectomy radiotherapy and regional nodal irradiation based on treatment response after neoadjuvant chemotherapy for breast cancer : A systematic review.
Krug D; Baumann R; Budach W; Dunst J; Feyer P; Fietkau R; Haase W; Harms W; Hehr T; Piroth MD; Sedlmayer F; Souchon R; Wenz F; Sauer R
Strahlenther Onkol; 2018 Jul; 194(7):607-618. PubMed ID: 29383405
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant chemotherapy in breast cancer.
Charfare H; Limongelli S; Purushotham AD
Br J Surg; 2005 Jan; 92(1):14-23. PubMed ID: 15635596
[TBL] [Abstract][Full Text] [Related]
20. Use of sentinel node biopsy expands.
Peres J
J Natl Cancer Inst; 2013 Oct; 105(19):1423-4. PubMed ID: 24052620
[No Abstract] [Full Text] [Related]
[Next] [New Search]
